Clinical Trial

BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

Study acronym: BRAVE
Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-24
notable Primary completion pushed: 2026-08 -> 2027-08 2026-07-24
minor Completion pushed: 2026-08 -> 2027-08 2026-07-24
Trial Details
NCT Number NCT07417904
Lead Sponsor Howard University
Collaborators: National Institute of Mental Health (NIMH)
Conditions Violence Risk, Early Psychosis
Enrollment 30 participants
Start Date 2026-07-02
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-29